BMGL
Basel Medical Group Ltd Ordinary Shares
NASDAQ: BMGL · HEALTHCARE · MEDICAL CARE FACILITIES
$4.60
-0.65% today
Updated 2026-10-28
Market cap
$6.41M
P/E ratio
—
P/S ratio
0.44x
EPS (TTM)
$-4.98
Dividend yield
—
52W range
$3 – $20
Volume
1.0M
Basel Medical Group Ltd Ordinary Shares (BMGL) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$4.60
12-Month target
—
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.0B | $0.0B |
| EPS | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -68.20%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.